Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-07-06
Original SEC Filing: Click here

---

Webplus: SVA/20200706/6-K/2_EX-99.1/000.htm SEC Original: tm2024136d1_ex99-1.htm
Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial Beijing-July 6, 2020 — Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products . Mr. Weidong Yin, Chairman,

---

---

Webplus: SVA/20200706/6-K/1/000.htm SEC Original: tm2024136d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-07-06CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200